TABLE 1.
Demographic characteristics of the study participantsa
| Characteristic | Result for vaccine group |
||||
|---|---|---|---|---|---|
| MenABCWY (n = 100) | 4CMenB+MenACWY/S (n = 104) | 4CMenB+MenACWY/D (n = 100) | 4CMenB (n = 94) | MenACWY (n = 102) | |
| Age (yr), mean ± SD | 17.1 ± 4.34 | 16.9 ± 4.28 | 17.1 ± 4.49 | 17.4 ± 4.64 | 17.1 ± 4.57 |
| Age range, no. (%) | |||||
| 10–17 yr | 53 (53.0) | 50 (48.1) | 48 (48.0) | 49 (52.1) | 50 (49.0) |
| 18–25 yr | 47 (47.0) | 54 (51.9) | 52 (52.0) | 45 (47.9) | 52 (51.0) |
| Male, no. (%) | 53 (53.0) | 56 (53.8) | 51 (51.0) | 41 (43.6) | 53 (52.0) |
a
All participants were randomized. SD, standard deviation; /S, vaccines administered concomitantly in the same arm; /D, vaccines administered concomitantly in different arms; n, number of participants; no., number of participants in a specific category; yr, years.